Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK)

CUSIP: 86150R107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
57,529,259
Total 13F shares
54,138,461
Share change
+9,100,250
Total reported value
$730,867,238
Put/Call ratio
183%
Price per share
$13.50
Number of holders
101
Value change
+$123,726,512
Number of buys
65
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) as of Q1 2024

As of 31 Mar 2024, Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,138,461 shares. The largest 10 holders included Skorpios Trust, Redmile Group, LLC, RTW INVESTMENTS, LP, MORGAN STANLEY, BlackRock Inc., Lynx1 Capital Management LP, BAKER BROS. ADVISORS LP, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, and GOLDMAN SACHS GROUP INC. This page lists 101 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.